ROYAL BANK OF CANADA - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 144 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is 2.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$877,000
-59.8%
707,848
-0.1%
0.00%
-100.0%
Q1 2017$2,181,000
-25.5%
708,334
-1.3%
0.00%
-50.0%
Q4 2016$2,928,000
-35.5%
717,754
+0.4%
0.00%
-33.3%
Q3 2016$4,540,000
+15.7%
715,064
-1.8%
0.00%
+50.0%
Q2 2016$3,925,000
-35.7%
728,334
-0.2%
0.00%
-50.0%
Q1 2016$6,105,000
+18.1%
729,484
+11.5%
0.00%
+33.3%
Q4 2015$5,170,000
+1026.4%
654,297
+1114.8%
0.00%
Q3 2015$459,000
-40.2%
53,862
-13.3%
0.00%
-100.0%
Q2 2015$767,000
+9.3%
62,103
+5.1%
0.00%
Q1 2015$702,000
-59.1%
59,103
-61.1%
0.00%
-100.0%
Q4 2014$1,715,000
+74.5%
151,803
+35.5%
0.00%0.0%
Q3 2014$983,000
+32.8%
112,003
+10.3%
0.00%0.0%
Q2 2014$740,000
+42.3%
101,503
-1.5%
0.00%
Q1 2014$520,000
+4627.3%
103,003
+4804.9%
0.00%
Q4 2013$11,000
-35.3%
2,100
-51.8%
0.00%
Q3 2013$17,000
+30.8%
4,353
+112.3%
0.00%
Q2 2013$13,0002,0500.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q4 2014
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 5,000,000$20,400,0004.19%
Consonance Capital Management LP 9,067,998$36,997,0004.06%
Lagoda Investment Management, L.P. 1,522,529$6,212,0002.13%
INDUS CAPITAL PARTNERS, LLC 1,050,000$4,284,0000.56%
WESTFIELD CAPITAL MANAGEMENT CO LP 9,072,877$37,017,0000.32%
GARRISON BRADFORD & ASSOCIATES INC 77,700$317,0000.29%
Cannell & Co. 1,572,978$6,418,0000.23%
Virtus ETF Advisers LLC 179,625$733,0000.22%
LeJeune Puetz Investment Counsel LLC 3,976$161,0000.12%
STONERIDGE INVESTMENT PARTNERS LLC 221,838$905,0000.12%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders